<SEC-DOCUMENT>0001129928-17-000005-index.html : 20170508
<SEC-HEADER>0001129928-17-000005.hdr.sgml : 20170508
<ACCEPTANCE-DATETIME>20170508150955
ACCESSION NUMBER:		0001129928-17-000005
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20170331
FILED AS OF DATE:		20170508
DATE AS OF CHANGE:		20170508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062
		FILM NUMBER:		17821924

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>firstquarter20176-k.htm
<DESCRIPTION>2017 FIRST QUARTER REPORT
<TEXT>
Document 1 - file: firstquarter20176-k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991interimfinancialstate.htm
<DESCRIPTION>2017 FIRST QUARTER INTERIM FINANCIAL STATEMENTS
<TEXT>
Document 2 - file: ex991interimfinancialstate.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ex992-q12017mda.htm
<DESCRIPTION>2017 FIRST QUARTER MD&A
<TEXT>
Document 3 - file: ex992-q12017mda.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>apc2.jpg
<TEXT>
Document 4 - file: apc2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ittgroup.jpg
<TEXT>
Document 5 - file: ittgroup.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>oncylogoa04.jpg
<TEXT>
Document 6 - file: oncylogoa04.jpg

</DOCUMENT>
</SEC-DOCUMENT>